Ignite Creation Date:
2024-05-06 @ 12:14 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03704480
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-05
First Post:
2018-09-28
Brief Title:
Durvalumab Tremelimumab Paclitaxel in Advanced BTC After Platinum Chemotherapy
Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Organization:
GERCOR - Multidisciplinary Oncology Cooperative Group
Organization Data
Organization:
GERCOR - Multidisciplinary Oncology Cooperative Group
Class:
OTHER
Study ID:
IMMUNO-BIL D18-1 PRODIGE 57
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |